As of the latest SEC filings, Scinai Immunotherapeutics Ltd. (SCNI) is held by 1 institutional funds. The largest fund shareholder is State Street(R) SPDR(R) Portfolio Developed World ex-US ETF (SPDW), holding an estimated $1.11 in market value, representing a significant portion of its portfolio.